Heterocyclic compounds form the backbone of a vast array of modern pharmaceuticals, playing crucial roles in drug efficacy and specificity. These cyclic molecules, containing at least one atom other than carbon within their ring structure, are indispensable in medicinal chemistry. Among the most vital are heterocyclic intermediates, which serve as pre-formed molecular fragments that streamline complex drug synthesis.

One such significant intermediate is (2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic Acid tert-butyl Ester, known by its CAS number 401564-36-1. This compound, featuring both pyrrolidine and thiazolidine rings, is a testament to the intricate structures utilized in advanced pharmaceutical research. Its primary application lies in the synthesis of DPP-IV inhibitors, a class of oral hypoglycemic agents used to manage type 2 diabetes. Specifically, it is a key intermediate for Teneligliptin, a widely prescribed drug in this category.

For research scientists and product formulators, understanding the properties and potential applications of such intermediates is critical. When searching for this specific compound, terms like 'buy CAS 401564-36-1' or 'pharmaceutical intermediate manufacturer' will lead you to specialized chemical suppliers. These suppliers offer critical information regarding the product's purity, physical state (typically a solid), and its chemical synthesis pathway. It is advisable to seek out suppliers who can provide detailed technical data and documentation to ensure the compound's suitability for your intended use.

The global market for pharmaceutical intermediates is highly competitive. Manufacturers, often located in regions with strong chemical synthesis infrastructure like China, strive to offer products with high enantiomeric purity and consistent quality. For procurement professionals, identifying a reliable supplier that can guarantee continuous availability and competitive price for intermediates like (2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic Acid tert-butyl Ester is a strategic objective. This ensures that R&D projects and large-scale manufacturing processes are not hampered by supply chain disruptions.

The demand for sophisticated heterocyclic intermediates like CAS 401564-36-1 is driven by the continuous innovation in drug discovery. As medicinal chemists design more complex and targeted therapies, the need for readily available, high-quality building blocks will only grow. Therefore, establishing strong relationships with trusted chemical manufacturers and suppliers is fundamental for anyone involved in pharmaceutical R&D and production.